Addex partners to treat addiction

Addex Therapeutics Ltd has leveraged more than a decade of research into addiction with a partnership that will see it co-develop a portfolio product with Indivior Plc, a London-listed and US headquartered specialty pharmaceutical company.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Switzerland